CME Group/$CME
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About CME Group
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
Ticker
$CME
Sector
Primary listing
Industry
Capital Markets
Headquarters
Employees
3,760
ISIN
US12572Q1058
Website
CME Group Metrics
BasicAdvanced
$99B
27.64
$9.94
0.47
$10.60
1.82%
Price and volume
Market cap
$99B
Beta
0.47
52-week high
$290.79
52-week low
$193.17
Average daily volume
2.5M
Dividend rate
$10.60
Financial strength
Current ratio
1.017
Quick ratio
0.021
Long term debt to equity
13.852
Total debt to equity
12.65
Dividend payout ratio (TTM)
105.42%
Interest coverage (TTM)
25.11%
Profitability
EBITDA (TTM)
4,419.1
Gross margin (TTM)
100.00%
Net profit margin (TTM)
57.81%
Operating margin (TTM)
65.10%
Effective tax rate (TTM)
22.38%
Revenue per employee (TTM)
$1,670,000
Management effectiveness
Return on assets (TTM)
1.76%
Return on equity (TTM)
13.39%
Valuation
Price to earnings (TTM)
27.642
Price to revenue (TTM)
15.743
Price to book
3.66
Price to tangible book (TTM)
-28.92
Price to free cash flow (TTM)
25.816
Free cash flow yield (TTM)
3.87%
Free cash flow per share (TTM)
1,064.32%
Dividend yield (TTM)
3.86%
Forward dividend yield
1.82%
Growth
Revenue change (TTM)
11.73%
Earnings per share change (TTM)
13.21%
3-year revenue growth (CAGR)
10.44%
10-year revenue growth (CAGR)
7.04%
3-year earnings per share growth (CAGR)
9.17%
10-year earnings per share growth (CAGR)
10.88%
3-year dividend per share growth (CAGR)
8.30%
10-year dividend per share growth (CAGR)
9.42%
What the Analysts think about CME Group
Analyst ratings (Buy, Hold, Sell) for CME Group stock.
Bulls say / Bears say
CME Group reported a 12% increase in first-quarter profit to $956 million, driven by record trading volumes amid market volatility. (reuters.com)
The company achieved a record average daily volume of 29.8 million contracts in Q1 2025, a 13% year-over-year increase, indicating strong demand for its products. (reuters.com)
CME Group increased its quarterly dividend to $1.25 per share, reflecting confidence in its financial health and commitment to returning value to shareholders. (etfdailynews.com)
Operating expenses rose by 1.1% to $534.4 million in Q1 2025, primarily due to higher technology spending, which could pressure profit margins. (reuters.com)
CME Group faces potential competition from BGC Group's FMX Futures, which could impact its market share and revenue growth. (reuters.com)
Insider selling activity, such as the sale of 11,592 shares by insider Julie Winkler, may signal concerns about the company's future performance. (etfdailynews.com)
Data summarised monthly by Lightyear AI. Last updated on 24 Jun 2025.
CME Group Financial Performance
Revenues and expenses
CME Group Earnings Performance
Company profitability
CME Group News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for CME Group stock?
CME Group (CME) has a market cap of $99B as of June 30, 2025.
What is the P/E ratio for CME Group stock?
The price to earnings (P/E) ratio for CME Group (CME) stock is 27.64 as of June 30, 2025.
Does CME Group stock pay dividends?
Yes, the CME Group (CME) stock pays dividends to shareholders. As of June 30, 2025, the dividend rate is $10.6 and the yield is 1.82%. CME Group has a payout ratio of 105.42% on a trailing twelve-month basis.
When is the next CME Group dividend payment date?
The next CME Group (CME) dividend payment date is unconfirmed.
What is the beta indicator for CME Group?
CME Group (CME) has a beta rating of 0.47. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.